S&P ASX All Technology

US Dollar vs AUD

Register for real-time alerts, custom portfolio, and market movers

Get Started

ATAI ATAI Life Sciences NV

1.81

-0.06 (-3.21%)

Last Updated: 03:19:36

Delayed by 15 minutes

Biotech Rips In Anticipation Of Q3 Results

Certain events bring about volatility that creates massive opportunities for traders on either side of the screen. That’s exactly what happened on Tuesday after a...

To read the full story on AllPennyStocks.com, click here.

ATAI Life Sciences NV (NASDAQ:ATAI)
Historical Stock Chart
From Mar 2024 to Apr 2024

Click Here for more ATAI Life Sciences NV Charts.

ATAI Life Sciences NV (NASDAQ:ATAI)
Historical Stock Chart
From Apr 2023 to Apr 2024

Click Here for more ATAI Life Sciences NV Charts.

ATAI Life Sciences NV News

atai Life Sciences Announces Dosing of First Patient in Part 2 of Beckley Psytech’s Phase 2a Study Exploring BPL-003 Adjunctive to SSRIs in Patients with Treatment Resistant Depression
Wednesday 24 April 2024 (1 day ago) • GlobeNewswire Inc.

atai Life Sciences Announces the Publication of Beckley Psytech’s Phase 1 Study of BPL-003 in the Journal of Psychopharmacology
Wednesday 17 April 2024 (1 week ago) • GlobeNewswire Inc.

atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical Highlights
Thursday 28 March 2024 (4 weeks ago) • GlobeNewswire Inc.

atai Life Sciences Announces Positive Initial Results from Beckley Psytech’s Phase 2a Open Label Study of BPL-003 (Intranasal 5-MeO-DMT) in Treatment Resistant Depression
Wednesday 27 March 2024 (4 weeks ago) • GlobeNewswire Inc.

atai Life Sciences Announces First Participant Dosed in Phase 1b Trial of VLS-01
Tuesday 5 March 2024 (2 months ago) • GlobeNewswire Inc.

atai Life Sciences to Participate in the Upcoming TD Cowen 44th Annual Health Care Conference
Thursday 29 February 2024 (2 months ago) • GlobeNewswire Inc.

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 14 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 7 February 2024 (3 months ago) • Edgar (US Regulatory)

atai Life Sciences Appoints Anne Johnson as Chief Financial Officer
Wednesday 7 February 2024 (3 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 23 January 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 10 January 2024 (4 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 10 January 2024 (4 months ago) • Edgar (US Regulatory)

More ATAI Life Sciences NV News Articles

Woodside Petroleum

Sterling vs AUD

S&P ASX 300 Metals and M...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions